The global CAR T-cell therapy market is experiencing substantial development, driven by growing demand for cutting-edge cancer treatment options. Significant strides in research have resulted to the acceptance of several CAR T-cell therapies for a range of hematological malignancies. This, coupled with persistent efforts to expand treatment indicat… Read More

The global CAR T-cell therapy market is projected to undergo substantial growth over the forecast period of 2023 to 2028. This trend can be attributed to a number of factors, including growing prevalence of cancer, progresses in cell therapy technology, and supportive regulatory sentiments. The market is also being driven a expanding demand for adv… Read More